The role of αv integrins during angiogenesis

Molecular Medicine

Volumn 4, Issue 12, 1998, Pages 741-750

  Eliceiri, Brian P ^a   Cheresh, David A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ARGINYLGLYCYLASPARTIC ACID; CYTOKINE; INTEGRIN; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; MONOCLONAL ANTIBODY LM 609; SCLEROPROTEIN; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; CD51 ANTIGEN; LEUKOCYTE ANTIGEN;

ANGIOGENESIS; CANCER; CELL INTERACTION; CELL SURVIVAL; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; ENZYME REGULATION; EXTRACELLULAR MATRIX; HUMAN; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; SIGNAL TRANSDUCTION; TUMOR VASCULARIZATION; ANIMAL; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; ANTIGENS, CD; HUMANS; INTEGRIN ALPHAV; INTEGRINS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 0032216811     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401768     Document Type: Short Survey

References (82)

1. 1. Auerbach W, Auerbach R. (1994) Angiogenesis inhibition: a review. Pharmacol. Ther. 63: 265-311.
2. 2. Varner JA, Brooks PC, Cheresh DA. (1995) Review: the integrin αvβ3: angiogenesis and apoptosis. Cell. Adhes. Commun. 3: 367-374.
3. 3. Hanahan D, Folkman J. (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86: 353-364.
4. 4. Folkman J, Klagsburn M. (1987) Angiogenic factors. Science 235: 442-427.
5. 5. D'Amore PA, Thompson RW. (1987) Mechanisms of angiogenesis. Annu. Rev. Physiol. 49: 453-464.
6. 6. Grant DS, Tashiro K, Segui-Real B, Yamada Y, Martin GR, Kleinman HK. (1989) Two different laminin domains mediate the differentiation of human endothelial cells into capillary-like structures in vitro. Cell 58: 933-943.
7. 7. Senger DR. (1996) Molecular framework for angiogenesis: a complex web of interactions between extravasated plasma proteins and endothelial cell proteins induced by angiogenic cytokines [comment]. Am. J. Pathol. 149: 1-7.
8. Bischoff J. (1995) Approaches to studying cell adhesion molecules in angiogenesis. Trends Cell Biol. 5: 69-74.
9. 9. Koch AE, Polverini PJ, Kunkel SL, et al. (1992) Interleukin-8 as a macrophage-derived mediator of angiogenesis [sec comments]. Science 258: 1798-1801.
10. 10. Frenette PS, Mayadas TN, Rayburn H, Hynes RO, Wagner DD. (1996) Susceptibility to infection and altered hematopoiesis in mice deficient in both P-and E-selectins. Cell 84: 563-574.
11. 11. Felding-Habermann B, Silletti S, Mei F, et al. (1997) A single immunoglobulin-like domain of the human neural cell adhesion molecule L1 supports adhesion by multiple vascular and platelet integrins. J. Cell Biol. 139: 1567-1581.
12. 12. Guadagno TM, Ohtsubo M, Roberts JM, Assoian RK. (1993) A link between cyclin A expression and adhesion-dependent cell cycle progression [published erratum appears in Science (1994) 263: 455]. Science 262: 1572-1575.
13. 13. Varner JA, Emerson DA, Juliano RL. (1995) Integrin α5β1 expression negatively regulates cell growth: reversal by attachment to fibronectin. Mol. Biol. Cell 6: 725-740.
14. 14. Dike LE, Farmer SR. (1988) Cell adhesion induces expression of growth-associated genes in suspension-arrested fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 85: 6792-6796.
15. 15. Hynes RO. (1992) Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69: 11-25.
16. 16. Cheresh DA. (1993) Integrins: structure, function and biological properties. Adv. Mol. Cell Biol. 6: 225-252.
17. 17. Juliano RL, Haskill S. (1993) Signal transduction from the extracellular matrix. J. Cell Biol. 120: 577-585.
18. 18. Kornberg L, Earp HS, Parsons JT, Schaller M, Juliano RL. (1992) Cell adhesion or integrin clustering increases phosphorylation of a focal adhesion-associated tyrosine kinase. J. Biol. Chem. 267: 23439-23442.
19. 19. Guan JL, Shalloway D. (1992) Regulation of focal adhesion-associated protein tyrosine kinase by both cellular adhesion and oncogenic transformation. Nature 358: 690-692.
20. + antiporter by platelet-derived growth factor. Proc. Natl. Acad. Sci. U.S.A. 89: 6138-6141.
21. 21. Schwartz MA. (1993) Signaling by integrins: implications for tumorigenesis. Cancer Res. 53: 1503-1506.
22. 22. McNamee HP, Ingber DE, Schwartz MA. (1993) Adhesion to fibronectin stimulates inositol lipid synthesis and enhances PDGF-induced inositol lipid breakdown. J. Cell Biol. 121: 673-678.
23. 23. Meredith JE Jr., Fazeli B, Schwartz MA. (1993) The extracellular matrix as a cell survival factor. Mol. Biol. Cell 4: 953-961.
24. 24. Montgomery AM, Reisfeld RA, Cheresh DA. (1991) Integrin αvβ3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen. Proc. Natl. Acad. Sci. U.S.A. 91: 8856-8860.
25. 25. Brooks PC, Montgomery AM, Rosenfeld M, et al. (1994) Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79: 1157-1164.
26. 26. Cheng YF, Kramer RH. (1989) Human microvascular endothelial cells express integrin-related complexes that mediate adhesion to the extracellular matrix. J. Cell Physiol. 139: 275-286.
27. 27. Kubota Y, Kleinman HK, Martin GR, Lawley TJ. (1988) Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures. J. Cell Biol. 107: 1589-1598.
28. 28. Nicosia RF, Madri JA. (1987) The microvascular extracellular matrix. Developmental changes during angiogenesis in the aortic ring-plasma clot model. Am. J. Pathol. 128: 78-90.
29. 29. Iruela-Arispe ML, Hasselaar P, Sage H. (1991) Differential expression of extracellular proteins is correlated with angiogenesis in vitro. Lab. Invest. 64: 174-186.
30. 30. Montesano R, Orci L. (1985) Tumor-promoting phorbol esters induce angiogenesis in vitro. Cell 42: 469-477.
31. 31. Mignatti P, Tsuboi R, Robbins E, Rifkin DB. (1989) In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor-induced proteinases. J. Cell Biol. 108: 671-682.
32. 32. Fisher C, Gilbertson-Beadling S, Powers EA, Petzold G, Poorman R, Mitchell MA. (1994) Interstitial collagenase is required for angiogenesis in vitro. Dev. Biol. 162: 499-510.
33. 33. Clark RA, DellaPelle P, Manseau E, Lanigan JM, Dvorak HF, Colvin RB. (1982) Blood vessel fibronectin increases in conjunction with endothelial cell proliferation and capillary ingrowth during wound healing. J. Invest. Dermatol. 79: 269-276.
34. 34. Risau W, Lemmon V. (1988) Changes in the vascular extracellular matrix during embryonic vasculogenesis and angiogenesis. Dev. Biol. 125: 441-450.
35. 35. Jiang B, Liou GI, Behzadian MA, Caldwell RB. (1994) Astrocytes modulate retinal vasculogenesis: effects on fibronectin expression. J. Cell Sci. 107: 2499-2508.
36. 36. Ingber D. (1991) Extracellular matrix and cell shape: potential control points for inhibition of angiogenesis. J. Cell. Biochem. 47: 236-241.
37. 37. Senger DR, Claffey KP, Benes JE, Perruzzi CA, Sergiou AP, Detmar M. (1997) Angiogenesis promoted by vascular endothelial growth factor: regulation through α1β1 and α2β1 integrins. Proc. Natl. Acad. Sci. U.S.A. 94: 13612-13617.
38. 38. Haralabopoulos GC, Grant DS, Kleinman HK, Lelkes PI, Papaioannou SP, Maragoudakis ME. (1994) Inhibitors of basement membrane collagen synthesis prevent endothelial cell alignment in matrigel in vitro and angiogenesis in vivo. Lab. Invest. 71: 575-582.
39. 39. Hanemaaijer R, Koolwijk P, le Clercq L, de Vree WJ, van Hinsbergh VW. (1993) Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorhol ester. Biochem. J. 296: 803-809.
40. 40. Lohler J, Timpl R, Jaenisch R. (1984) Embryonic lethal mutation in mouse collagen 1 gene causes rupture of blood vessels and is associated with erythropoietic and mesenchymal cell death. Cell 38: 597-607.
41. 41. Brooks PC, Stromblad S, Sanders LC, et al. (1996) Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3. Cell 85: 683-693.
42. 42. Takigawa M, Enomoto M, Nishida Y, Pan HO, Kinoshita A, Suzuki F. (1990) Tumor angiogenesis and polyamines: α-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits B16 melanoma-induced angiogenesis in ovo and the proliferation of vascular endothelial cells in vitro. Cancer Res. 50: 4131-4138.
43. 45. Moses MA, Sudhalter J, Langer R. (1990) Identification of an inhibitor of neovascularization from cartilage. Science 248: 1408-1410.
44. 44. Johnson MD, Kim HR, Chesler L, Tsao-Wu G, Bouck N, Polverini PJ. (1994) Inhibition of angiogenesis by tissue inhibitor of metalloproteinase. J. Cell. Physiol. 160: 194-202.
45. 45. Davis GE. (1992) Affinity of integrins for damaged extracellular matrix: αvβ3 binds to denatured collagen type I through RGD sites. Biochem. Biophys. Res. Commun. 182: 1025-1031.
46. 46. Pfaff M, Aumailley M, Specks U, Knolle J, Zerwes HG, Timpl R. (1993) Integrin and Arg-Gly-Asp dependence of cell adhesion to the native and unfolded triple helix of collagen type VI. Exp. Cell Res. 206: 167-176.
47. 47. Brooks PC, Clark RA, Cheresh DA. (1994) Requirement of vascular αvβ3 integrin for angiogenesis. Science 264: 569-571.
48. 48. Cheresh DA. (1987) Human endothelial cells synthesize and express an Arg-Gly-Asp-directed adhesion receptor involved in attachment to fibrinogen and von Willebrand factor. Proc. Natl. Acad. Sci. U.S.A. 84: 6471-6475.
49. 49. Leavesley DI, Ferguson GD, Wayner EA, Cheresh DA. (1992) Requirement of the integrin beta 3 subunit for carcinoma cell spreading or migration on vitronectin and fibrinogen. J. Cell Biol. 117: 1101-1107.
50. 50. Brem RB, Robbins SG, Wilson DJ, O'Rourke LM, Mixon RN, Robertson JE, Planck SR, Rosenbaum JT. (1994) Immunolocalization of integrins in the human retina. Invest. Ophthalmol. Vis. Sci. 35: 3466-3474.
51. 51. Sato M, Sardana MK, Grasser WA, Garsky VM, Murray JM, Gould RJ. (1990) Echistatin is a potent inhibitor of hone resorption in culture. J. Cell Biol. 111: 1713-1723.
52. 52. Horton MA, Taylor ML, Arnett TR, Helfrich MH. (1991) Arg-Gly-Asp (RGD) peptides and the antivitronectin receptor antibody 23C6 inhibit dentine resorption and cell spreading by osteoclasts. Exp. Cell Res. 195: 368-375.
53. 53. Ross FP, Chappel J, Alvarez JI, et al. (1993) Interactions between the bone matrix proteins osteopontin and bone sialoprotein and the osteoclast integrin αvβ3 potentiate bone resorption. J, Biol. Chem. 268: 9901-9907.
54. 54. Albelda SM, Mette SA, Elder DE, et al. (1990) Integrin distribution in malignant melanoma: association of the beta 3 subunit with tumor progression. Cancer Res. 50: 6757-6764.
55. 55. Gladson CL, Cheresh DA. (1991) Glioblastoma expression of vitronectin and the αvβ3 integrin. Adhesion mechanism for transformed glial cells. J. Clin. Invest. 88: 1924-1932.
56. 56. Enenstein J, Kramer RH. (1994) Confocal microscopic analysis of integrin expression on the microvasculature and its sprouts in the neonatal foreskin. J. Invest. Dermatol. 103: 381-386.
57. 57. Sepp NT, Li LJ, Lee KH, et al. (1994) Basic fibroblast growth factor increases expression of the αvβ3 integrin complex on human microvascular endothelial cells. J. Invest. Dermatol. 103: 295-299.
58. 58. Liaw L, Skinner MP, Raines EW, et al. (1995) The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of αvβ3 in smooth muscle cell migration to osteopontin in vitro. J. Clin. Invest. 95: 713-724.
59. 59. Topol EJ, Califf RM, Weisman HF, et al. (1994) Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. The EPIC Investigators [see comments]. Lancet 343: 881-886.
60. 60. Enenstein J, Waleh NS, Kramer RH. (1992) Basic FGF and TGF-β differentially modulate integrin expression of human microvascular endothelial cells. Exp. Cell Res. 203: 499-503.
61. 61. Boudreau N, Andrews C, Srebrow A, Ravanpay A, Cheresh DA. (1997) Induction of the angiogenic phenotype by Hox D3. J. Cell. Biol. 139: 257-264.
62. 62. Friedlander M, Brooks PC, Shaffer RW, Kincaid CM, Varner JA, Cheresh DA. (1995) Definition of two angiogenic pathways by distinct alpha v integrins. Science 270: 1500-1502.
63. 63. Friedlander M, Theesfeld CL, Sugita M, Fruttiger M, Thomas MA, Chang S, Cheresh DA. (1996) Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases. Proc. Natl. Acad. Sci. U.S.A. 93: 9764-9769.
64. 64. Drake CJ, Cheresh DA, Little CD. (1995) An antagonist of integrin vβ3 prevents maturation of blood vessels during embryonic neovascularization. J. Cell. Sci. 108: 2655-2661.
65. 65. Brooks PC, Stromblad S, Klemke R, Visscher D, Sarkar FH, Cheresh DA. (1995) Antiintegrin αvβ3 blocks human breast cancer growth and angiogenesis in human skin [sec comments]. J. Clin. Invest. 96; 1815-1822.
66. 66. Hammes HP, Brownlee M, Jonczyk A, Sutter A, Preissner KT. (1996) Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization. Nat. Med. 2: 529-533.
67. 67. Eliceiri BP, Klemke R, Stromblad S, Cheresh DA. (1998) Integrin αvβ3 requirement for sustained mitogen-activated protein kinase activity during angiogenesis. J. Cell Biol. 140: 1255-1263.
68. 68. Coller BS, Cheresh DA, Asch E, Seligsohn U. (1991) Platelet vitronectin receptor expression differentiates Iraqi-Jewish from Arab patients with Glanzmann thrombasthenia in Israel. Blood 77: 75-83.
69. 69. Djaffar I, Rosa JP. (1993) A second case of variant of Glanzmann's thrombasthenia due to substitution of platelet GPIIIa (integrin beta 3) Arg214 by Trp. Hum. Mol. Genet. 2: 2179-2180.
70. 70. Bader B, Rayburn H, Crowley D, Hynes RO. (1998) Extensive vasculogenesis, angiogenesis and organogenesis precede lethality in mice lacking all αv integrins. Cell 95: 507-519.
71. 71. Hodivala-Dilke KM, McHugh K, Tsakiris DA, et al. (1997) Beta-3 knockout mice display a Glanzmann thrombastemia phenotype [abstract]. Blood 537.
72. 3 inhibits Leydig cell tumor growth and the development of hypercalcemia of malignancy. Cancer Res. 58: 1930-1935.
73. 73. Storgard CM, Stupack DG, Joncyk A, Goodman SL, Fox RI, Cheresh DA. (1999) Decreased angiogenesis and arthritic disease in rabbits treated with an αvβ3 antagonist. J. Clin. Invest. (in press)
74. 74. Sipkins DA, Cheresh DA, Kazemi MR, Nevin LM, Bednarski MD, Li KC. (1998) Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging. Nat. Med. 4: 623-626.
75. 75. Re F, Zanetti A, Sironi M, et al. (1994) Inhibition of anchorage-dependent cell spreading triggers apoptosis in cultured human endothelial cells. J. Cell Biol. 127: 537-546.
76. 76. Stromblad S, Becker JC, Yebra M, Brooks PC, Cheresh DA. (1996) Suppression of p53 activity and p21 WAF1/CIP1 expression by vascular cell αvβ3 inlegrin during angiogenesis. J. Clin. Invest. 98: 426-433.
77. 77. White E. (1996) Life, death, and the pursuit of apoptosis. Genes Dev. 10: 1-15.
78. 78. Miyamoto S, Teramoto H, Gutkind JS, Yamada KM. (1996) Integrins can collaborate with growth factors for phosphorylation of receptor tyrosine kinases and MAP kinase activation: roles of integrin aggregation and occupancy of receptors. J. Cell Biol. 135: 1633-1642.
79. 79. Schwartz MA, Schaller MD, Ginsberg MH. (1995) Integrins: emerging paradigms of signal transduction. Annu. Rev. Cell. Dev. Biol. 11: 549-599.
80. 80. Marshall CJ. (1995) Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80: 179-185.
81. 81. Traverse S, Gomez N, Paterson H, Marshall C, Cohen P. (1992) Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor. Biochem. J. 288: 351-355.
82. 82. Milne DM, Campbell DG, Caudwell FB, Meek DW. (1994) Phosphorylation of the tumor suppressor protein p53 by mitogen-activated protein kinases. J. Biol. Chem. 269: 9253-9260.